1 Finch, S, Doyle, W, Lowe, C, et al. (1998) National Diet and Nutrition Survey: People Aged 65 Years or Over. vol. 1: Report of the Diet and Nutrition Survey. London: The Stationery Office.
2 Kannel, WB (2002) Coronary heart disease risk factors in the elderly. Am J Geriatr Cardiol 11, 101–107.
3 de Ruijter, W, Westendorp, RGJ, Assendelft, WJJ, et al. (2009) Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ 338, a3083.
4 Perry, I, Refsum, H, Morris, R, et al. (1996) Serum total homocysteine and coronary heart disease in middle-aged British men. Heart 75, Suppl. 1, 53 .
5 Verhoef, P, Stampfer, MJ, Buring, JE, et al. (1996) Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol 143, 845–859.
6 Nygard, O, Nordrehaug, JE, Refsum, H, et al. (1997) Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337, 230–236.
7 Homocysteine-Lowering Triallists' Collaboration (1998) Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 316, 894–898.
8 Bostom, AG, Silbershatz, H, Rosenberg, IH, et al. (1999) Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med 159, 1077–1080.
9 Kark, JD, Selhub, J, Adler, B, et al. (1999) Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem. Ann Intern Med 131, 321–330.
10 Whincup, P, Refsum, H, Perry, I, et al. (1999) Serum total homocysteine and coronary heart disease: prospective study in middle aged men. Heart 82, 448–454.
11 Anderson, JL, Muhlestein, JB, Horne, BD, et al. (2000) Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation 102, 1227–1232.
12 Omland, T, Samuelsson, A, Hartford, M, et al. (2000) Serum homocysteine as an indicator of survival in patients with acute coronary syndromes. Arch Intern Med 160, 1834–1840.
13 Zhao, X-Q, Kosinski, A, Malinow, MR, et al. (2000) Association of total plasma homocyst(e)ine levels and 8-years mortality following PTCA or CABG in EAST. Circulation 102 .
14 Vollset, SE, Refsum, H, Tverdal, A, et al. (2001) Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. Am J Clin Nutr 74, 130–136.
15 Blacher, J, Benetos, A, Kirzin, JM, et al. (2002) Relation of plasma total homocysteine to cardiovascular mortality in a French population. Am J Cardiol 90, 591–595.
16 Zylberstein, DE, Bengtsson, C, Bjorkelund, C, et al. (2004) Serum homocysteine in relation to morbidity and mortality from coronary heart disease: a 24-year follow-up of the population study of women in Gothenburg. Circulation 109, 601–606.
17 Virtanen, JK, Voutilainen, S, Alfthan, G, et al. (2005) Homocysteine as a risk factor for CVD mortality in men with other CVD risk factors. J Intern Med 257, 255–262.
18 Menon, V, Sarnak, MJ, Greene, T, et al. (2006) Relationship between homocysteine and mortality in chronic kidney disease. Circulation 113, 1572–1577.
19 Refsum, H, Nurk, E, Smith, AD, et al. (2006) The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. Am J Clin Nutr 136, 1731S–1740S.
20 Rossi, GP, Maiolino, G, Seccia, TM, et al. (2006) Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women. J Hypertens 24, 851–859.
21 Selhub, J (2006) The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J Nutr 136, 1726S–1730S.
22 Gonzalez, S, Huerta, JM, Fernandez, S, et al. (2007) Homocysteine increases the risk of mortality in elderly individuals. Br J Nutr 97, 1138–1143.
23 Dangour, AD, Breeze, E, Clarke, R, et al. (2008) Plasma homocysteine, but not folate or vitamin B-12, predicts mortality in older people in the United Kingdom. J Nutr 138, 1121–1128.
24 Mansoor, M, Svardal, A & Ueland, P (1992) Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine and glutathione in human plasma. Anal Biochem 200, 218–229.
25 Bates, CJ, Pentieva, KD, Matthews, N, et al. (1999) A simple, sensitive and reproducible assay for pyridoxal phosphate in human plasma. Clin Chim Acta 280, 101–111.
26 Stolzenberg-Solomon, RZ, Miller, ER, Maguire, MG, et al. (1999) Association of dietary protein intake and coffee consumption with serum homocysteine concentrations in an older population. Am J Clin Nutr 69, 467–475.
27 Danesh, J, Wheeler, JG, Hirschfield, GM, et al. (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350, 1387–1397.
28 Bates, CJ, Mansoor, MA, Gregory, J, et al. (2002) Correlates of plasma homocysteine, cysteine and cysteinyl-glycine in respondents in the British National Diet and Nutrition Survey of young people aged 4–18 years, and a comparison with the survey of people aged 65 years and over. Br J Nutr 87, 71–79.
29 Haim, M, Tanne, D, Goldbourt, U, et al. (2006) Serum homocysteine and long-term risk of myocardial infarction and sudden death in patients with coronary heart disease. Cardiology 107, 52–56.
30 Jia, X, Aucott, LS & McNeill, G (2007) Nutritional status and subsequent all-cause mortality in men and women aged 75 years or over living in the community. Br J Nutr 98, 593–599.
31 Bates, CJ, Mansoor, MA, van der Pols, JC, et al. (1998) Plasma total homocysteine in 972 British men and women aged 65 years and over. Eur J Clin Nutr 51, 691–697.
32 Bates, CJ, Pentieva, KD & Prentice, A (1999) An appraisal of vitamin B6 status indices and associated confounders, in young people aged 4–18 years and in people aged 65 years and over, in two national British surveys. Public Health Nutr 2, 529–535.
33 Bates, CJ, Pentieva, KD, Prentice, A, et al. (1999) Plasma pyridoxal phosphate and pyridoxic acid and their relationship to plasma homocysteine in a representative sample of British men and women aged 65 years and over. Br J Nutr 81, 191–201.
34 Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288, 2015–2022.
35 Wald, DS, Law, M & Morris, JK (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325, 1202–1206.
36 Cesari, M, Onder, G, Zamboni, V, et al. (2009) C-reactive protein and lipid parameters in older persons aged 80 years and older. J Nutr Health Aging 13, 587–593.
37 Zethelius, B, Berglund, L, Sundström, J, et al. (2008) Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 358, 2107–2116.
38 Bates, CJ, Lean, MEJ, Mansoor, MA, et al. (2004) Nutrient intakes: biochemical and risk indices associated with type 2 diabetes and glycosylated haemoglobin, in the British National Diet and Nutrition Survey of people aged 65 years and over. Diabet Med 21, 677–684.
39 Chonchol, M, Katz, R, Fried, LF, et al. (2010) Glycosylated hemoglobin and the risk of death and cardiovascular mortality in the elderly. Nutr Metab Cardiovasc Dis 20, 15–21.
40 Hamer, M, Bates, CJ & Mishra, GD (2010) Depressive symptoms, physical function, and risk of mortality: National Diet and Nutrition Survey in older adults 65+ years. Am J Geriatr Psychiat .
41 Virtanen, JK, Voutilainen, S, Rissanen, TH, et al. (2005) High dietary methionine intake increases the risk of acute coronary events in middle-aged men. Nutr Metab Cardiovasc Dis 16, 113–120.